0 votes
asked ago by (54.9k points)
edited ago by
June 30 --  The Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS), invites the public to send comments to OMB by August 2, 2021 regarding the 2022 National Survey on Drug Use and Health (NSDUH).
NSDUH began in 1971 and has been conducted every year since 1990. NSDUH data are used to determine the prevalence of use of tobacco products, alcohol, illicit substances, and illicit use of prescription drugs. The results are used by SAMHSA, the Office of National Drug Control Policy (ONDCP), federal government agencies, and other organizations and researchers to establish policy, direct program activities, and better allocate resources.
Unlike previous NSDUHs, a hybrid address-based sampling (ABS) design will be implemented for the 2022 NSDUH. ABS refers to the sampling of residential addresses from a list based on the U.S. Postal Service's Computerized Delivery Sequence file. In areas with high expected ABS coverage, the ABS frame will be used. In all other areas, traditional field enumeration will be used to construct the dwelling unit frames.

The NSDUH questionnaire must be updated periodically to reflect changing substance use and mental health issues and to continue producing current data. For the 2022 NSDUH, the following questionnaire updates are planned: (1) Replacing the tobacco module with a redesigned nicotine module that includes questions about vaping, removes low priority items to reduce respondent burden and eliminates outdated terminology; (2) revising the marijuana module to include questions about the use of CBD, update questions on the mode of administration and eliminate outdated terminology and includes changes to the market information for marijuana questions; (3) redesigning the adult and youth mental health services utilization modules into one Mental Health Service Utilization model to remove questions with outdated terminology and include questions about newer treatments with recent increases in popularity; and (4) replacing the drug treatment module with a redesigned alcohol and drug treatment module that includes questions about newer treatments and those that have increased in popularity, as well as eliminating outdated terminology and reducing respondent burden.

As with all NSDUH/NHSDA surveys conducted since 1999, the 2022 NSDUH will continue to use a sample design which provides data at both the national level and the state level. The survey’s sample design includes targets to yield 4,560 completed interviews in California; 3,300 completed interviews each in Texas, New York, and Florida; 2,400 completed interviews each in Illinois, Pennsylvania, Ohio, and Michigan; 1,500 completed interviews each in Georgia, North Carolina, New Jersey, and Virginia; 967 completed interviews in Hawaii; and 960 completed interviews in each of the remaining 37 states and the District of Columbia. This approach will ensure a sufficient sample in every state to support either small area estimation (SAE) or direct estimation methods while at the same time maintaining efficiency for national estimates.
NSDUH webpage:  https://nsduhweb.rti.org/respweb/homepage.cfm
2022 NSDUH submission to OMB: https://www.reginfo.gov/public/do/PRAViewICR?ref_nbr=202106-0930-001 Click IC List for form, View Supporting Statement for technical documentation
FR notice inviting public comments: https://www.federalregister.gov/documents/2021/06/30/2021-13937/agency-information-collection-activities-submission-for-omb-review-comment-request
Point of contact: Rong Cai, SAMHSA Project Officer Rong.Cai@samhsa.hhs.gov
For AEA members wishing to submit comments to OMB, "A Primer on How to Respond to Calls for Comment on Federal Data Collections" is available at https://www.aeaweb.org/content/file?id=5806

Please log in or register to answer this question.